AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Confronting Smallpox.(biohazard precautions United States)(Brief Article)

Newsweek International

| December 23, 2002 | Cowley, Geoffrey; Piore, Adam; Underwood, Anne; Rosenberg, Debra; Lipper, Tamara; Carmichael, Mary; Noonan, David; Springen, Karen; Breslau, Karen; Murr, Andrew; Gesalman, Anne Belli | COPYRIGHT 2002 Newsweek, Inc. All rights reserved. Any reuse, distribution or alteration without express written permission of Newsweek is prohibited. For permission: www.newsweek.com. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

The defeat of the deadly smallpox virus still stands as one of modern science's most stunning achievements. The wretched disease engulfs the body in pustules that itch and ooze and often blind or disfigure victims who survive. Smallpox killed a half-billion people between 1880 and 1980, the year the World Health Organization declared the disease "eradicated." The victory was fueled by a vaccine that uses a milder but still-dangerous relative of the smallpox virus to provoke an immune response. The vaccine hasn't been used widely since the early 1980s, but the specter of bioterrorism has resurrected it. Last Friday, President George W. Bush ordered vaccinations for U.S. military personnel serving in high-risk areas. He also announced plans to offer the shot to health-care and emergency workers--and eventually to the public. "It is prudent to prepare for the possibility that terrorists... would use disease as a weapon," Bush said.

But does vaccination pose a greater risk than the threat of terrorism? That's a question health officials will no doubt be grappling with in the coming months as they debate exactly who else should be protected and how best to deploy the vaccine. Throughout the 1980s and 1990s, the variola virus, which causes smallpox, remained very much alive in Soviet military laboratories, and their stockpile has never been fully accounted for. Many fear that samples could fall into the hands of terrorists--if they haven't already. Iraq may also possess clandestine samples. But the vaccine itself poses real hazards. According to the U.S. Centers for Disease Control and Prevention, 15 of every million people receiving the vaccine for the first time could suffer life- threatening reactions--conditions such as encephalitis (brain inflammation), generalized vaccinia (a systemic infection from the vaccinia virus) and eczema vaccinatum (a widespread skin eruption).

President Bush acknowledged the dilemma when he unveiled his plan. He stopped short of ordering vaccinations for the general public, citing the vaccine's "inherent health risks." By 2004, however, Bush plans to make the vaccine available to almost anyone who wants it. Routine vaccination could prove far more dangerous today than it was before the vaccine went out of use two decades ago. In an age of AIDS, chemotherapy and organ transplants, millions more people now live with compromised immune systems. Those people are all at high risk of complications from the vaccine.

Two leading U.S. experts highlight the debate. Back in 1969, Drs. Donald Millar and Michael Lane wrote a seminal paper on smallpox vaccinations, declaring that they were no longer necessary in the United States. Smallpox itself had not been seen in the country since 1948, yet thousands of children were suffering adverse reactions to the vaccine, and roughly one in a million was dying of complications. "The benefits of ...

Related articles from newspapers, magazines, journals, and more
United States Pledges 20 Million Doses of Smallpox Vaccine to Global Stockpile.
Press release article from: PR Newswire December 10, 2004 700+ words
...2001, the United States has dramatically...of smallpox vaccine available in...immediately make vaccine in the stockpile...to provide vaccines for its own...enough smallpox vaccine for every man...occurred in the United States in 1949, and...
Merck Vaccines Play Critical Role in Eliminating Health Threat from Rubella in...
Press release article from: Business Wire March 21, 2005 700+ words
...threat in the United States." The announcement...first U.S. vaccine against rubella...manufacturer of vaccines that protect...rubella in the United States today. Rubella...threat in the United States not only...using rubella vaccines," said...Program for ...
New Human Rabies Vaccine Approved in the United States.
Press release article from: Business Wire November 3, 1997 700+ words
...against rabies. The vaccine will be manufactured...distributed in the United States by Chiron Corporation...is the first new vaccine against rabies to be introduced in the United States in almost 10 years...president of Chiron Vaccines. "The production...
Connaught Laboratories to sponsor Japanese bivalent accellular pertussis...
Press release article from: PR Newswire April 21, 1988 700+ words
...Biken. The vaccine was used in...acellular pertussis vaccines in Sweden over...licensure of the new vaccine with the U...trials in the United States. The vaccine...of the Biken vaccine is estimated...studies in the United States and Canada in...new pertussis ...
Bavarian Nordic announces further investment in smallpox vaccine production and...
Newspaper article from: BIOTECH Patent News February 1, 2005 700+ words
...and smallpox vaccines are in clinical...patented under United States Patent 6,761...s smallpox vaccine), and its...to smallpox vaccines, Bavarian Nordic...expedited by the United States government with...ever smallpox vaccine candidate to...for smallpox vaccines, ...
Merck Sharp & Dohme Research Laboratories develops the first vaccine for...
Press release article from: PR Newswire July 23, 1986 700+ words
...Laboratories (MSDRL), the vaccine's developer. The new vaccine is for the prevention...liver disease in the United States and approximately...the forefront of vaccine research and development...development of future vaccines for improving human...
HHS Purchases 1.2 Million Doses of Flu Vaccine; GlaxoSmithKline Vaccine Adds to...
Press release article from: PR Newswire December 7, 2004 700+ words
...GlaxoSmithKline influenza vaccine, Fluarix, in the United States under an Investigational...the Fluarix vaccine will be sent to the United States for distribution...for use in the United States and will be administered...The Fluarix vaccine being purchased...
INSTITUT MERIEUX AND MERCK & CO., INC. CREATE RESEARCH AND MARKETING...
Press release article from: PR Newswire April 21, 1992 700+ words
...VACCINES IN THE UNITED STATES SWIFTWATER...pediatric vaccines as well as...selected vaccine products in the United States. The agreement...the Merck Vaccine Division...epidemics in the United States have underscored...existing vaccines to ...
For more facts and information, see all results

Source: HighBeam Research, Confronting Smallpox.(biohazard precautions United States)(Brief...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA